Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage

Brain Research

Volumn 1262, Issue , 2009, Pages 73-80

  Lu, Hua ^a   Shi, Ji Xin ^a   Chen, Hui Lin ^a   Hang, Chun Hua ^a   Wang, Han Dong ^a   Yin, Hong Xia ^a  

^a JINLING HOSPITAL   (China)

Author keywords

Inflammation; Monocyte chemoattractant protein 1; Rat; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BASILAR ARTERY; BRAIN ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; CROSS-SECTIONAL AREA; EXPERIMENTAL MODEL; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING;

ANIMALS; BASILAR ARTERY; CEREBROVASCULAR CIRCULATION; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

ANIMALIA; RATTUS;

EID: 62049084483     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.01.017     Document Type: Article

References (52)

1. Aihara Y., Kasuya H., Onda H., Hori T., and Takeda J. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32 (2001) 212-217
2. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., and Petrek M. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm. 2005 (2005) 175-179
3. Bavbek M., Polin R., Kwan A.L., Arthur A.S., Kassell N.F., and Lee K.S. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 29 (1998) 1930-1935
4. Biedermann B.C. Vascular endothelium: check point for inflammation and immunity. News Physiol. Sci. 16 (2001) 84-88
5. Broderick J.P., Brott T., Tomsick T., Huster G., and Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N. Engl. J. Med. 326 (1992) 733-736
6. Broderick J.P., Brott T.G., Duldner J.E., Tomsick T., and Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25 (1994) 1342-1347
7. Che X., Ye W., Panga L., Wu D.C., and Yang G.Y. Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res. 902 (2001) 171-177
8. Clatterbuck R.E., Gailloud P., Ogata L., Gebremariam A., Dietsch G.N., Murphy K.J., and Tamargo R.J. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J. Neurosurg. 99 (2003) 376-382
9. Colotta F., Borré A., Wang J.M., Tattanelli M., Maddalena F., Polentarutti N., Peri G., and Mantovani A. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J. Immunol. 148 (1992) 760-765
10. Daly C., and Rollins B.J. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10 (2003) 247-257
11. Desai A., Lankford H.A., and Warren J.S. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation 25 (2001) 179-186
12. Dumont A.S., Dumont R.J., Chow M.M., Lin C.L., Calisaneller T., Ley K.F., Kassell N.F., and Lee K.S. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53 (2003) 123-135
13. Findlay J.M., Weir B.K., Kanamaru K., and Espinosa F. Arterial wall changes in cerebral vasospasm. Neurosurgery 25 (1989) 736-745
14. Gaetani P., Tartara F., Pignatti P., Tancioni F., Rodriguez y Baena R., and De Benedetti F. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol. Res. 20 (1998) 337-342
15. Gallia G.L., and Tamargo R.J. Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol. Res. 28 (2006) 750-758
16. Gao X., Iwai M., Inaba S., Tomono Y., Kanno H., Mogi M., and Horiuchi M. Attenuation of monocyte chemoattractant protein-1 expression via inhibition of nuclear factor-kappaB activity in inflammatory vascular injury. Am. J. Hypertens. 20 (2007) 1170-1175
17. Handa Y., Hayashi M., Takeuchi H., Kobayashi H., Kawano H., and Kabuto M. Effect of cyclosporine on the development of cerebral vasospasm in a primate model. Neurosurgery 28 (1991) 380-385
18. Handa Y., Kabuto M., Kobayashi H., Kawano H., Takeuchi H., and Hayashi M. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 28 (1991) 542-549
19. Hop J.W., Rinkel G.J., Algra A., and van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 28 (1997) 660-664
20. Hughes P.M., Allegrini P.R., Rudin M., Perry V.H., Mir A.K., and Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow Metab. 22 (2002) 308-317
21. Ingall T., Asplund K., Mahonen M., and Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 31 (2000) 1054-1061
22. Kaikita K., Hayasaki T., Okuma T., Kuziel W.A., Ogawa H., and Takeya M. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am. J. Pathol. 165 (2004) 439-447
23. Kim Y.S., Ahn Y., Hong M.H., Joo S.Y., Kim K.H., Sohn I.S., Park H.W., Hong Y.J., Kim J.H., Kim W., Jeong M.H., Cho J.G., Park J.C., and Kang J.C. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J. Cardiovasc. Pharmacol. 50 (2007) 41-49
24. Kim G.H., Kellner C.P., Hahn D.K., Desantis B.M., Musabbir M., Starke R.M., Rynkowski M., Komotar R.J., Otten M.L., Sciacca R., Schmidt J.M., Mayer S.A., and Connolly E.S. Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. J. Neurosurg. 109 (2008) 38-43
25. Komotar R.J., Zacharia B.E., Valhora R., Mocco J., and Connolly E.S. Advances in vasospasm treatment and prevention. J. Neurol. Sci. 261 (2007) 134-142
26. Kubota T., Handa Y., Tsuchida A., Kaneko M., Kobayashi H., and Kubota T. The kinetics of lymphocyte subsets and macrophages in subarachnoid space after subarachnoid hemorrhage in rats. Stroke 24 (1993) 1993-2001
27. Kumagai N., Chiba Y., Hosono M., Fujii M., Kawamura N., Keino H., Yoshikawa K., Ishii S., Saitoh Y., Satoh M., Shimada A., and Hosokawa M. Involvement of pro-inflammatory cytokines and microglia in an age-associated neurodegeneration model, the SAMP10 mouse. Brain Res. 1185 (2007) 75-85
28. Lin C.I., Chen C.N., Chen J.H., and Lee H. Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. J. Cell. Biochem. 99 (2006) 1216-1232
29. Luscher T.F., and Barton M. Biology of the endothelium. Clin. Cardiol. 20 (1997) II-3-II-10
30. Martín-Ventura J.L., Ortego M., Esbrit P., Hernández-Presa M.A., Ortega L., and Egido J. Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 34 (2003) 1783-1789
31. Nishi T., Maier C.M., Hayashi T., Saito A., and Chan P.H. Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 25 (2005) 1312-1324
32. Onda H., Kasuya H., Takakura K., Hori T., Imaizumi T., Takeuchi T., Inoue I., and Takeda J. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 19 (1999) 1279-1288
33. Ortego M., Bustos C., Hernández-Presa M.A., Tuñón J., Díaz C., Hernández G., and Egido J. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147 (1999) 253-261
34. Peterson J.W., Nishizawa S., Hackett J.D., Bun T., Teramura A., and Zervas N.T. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 21 (1990) 133-137
35. Rankine E.L., Hughes P.M., Botham M.S., Perry V.H., and Felton L.M. Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur. J. Neurosci. 24 (2006) 77-86
36. Reynolds M.A., Kirchick H.J., Dahlen J.R., Anderberg J.M., McPherson P.H., Nakamura K.K., Laskowitz D.T., Valkirs G.E., and Buechler K.F. Early biomarkers of stroke. Clin. Chem. 49 (2003) 1733-1739
37. Satonaka H., Suzuki E., Nishimatsu H., Oba S., Takeda R., Goto A., Omata M., Fujita T., Nagai R., and Hirata Y. Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation. Circ. Res. 94 (2004) 693-700
38. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1950-1959
39. Schober A., and Zernecke A. Chemokines in vascular remodeling. Thromb. Haemost. 97 (2007) 730-737
40. Sercombe R., Dinh Y.R., and Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn. J. Pharmacol. 88 (2002) 227-249
41. Sica A., Wang J.M., Colotta F., Dejana E., Mantovani A., Oppenheim J.J., Larsen C.G., Zachariae C.O., and Matsushima K. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J. Immunol. 144 (1990) 3034-3038
42. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 266-274
43. Tanabe Y., Sakata K., Yamada H., Ito T., and Takada M. Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study. J. Neurosurg. 49 (1978) 229-238
44. Thompson W.L., Karpus W.J., and Van Eldik L.J. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J. Neuroinflammation 15 (2008) 35-42
45. Wang X., Yue T.L., Barone F.C., and Feuerstein G.Z. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 26 (1995) 661-665
46. Yamagami S., Tamura M., Hayashi M., Endo N., Tanabe H., Katsuura Y., and Komoriya K. Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J. Leukoc. Biol. 65 (1999) 744-749
47. Yan Y.P., Sailor K.A., Lang B.T., Park S.W., Vemuganti R., and Dempsey R.J. Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 27 (2007) 1213-1224
48. Yatsushige H., Yamaguchi M., Zhou C.M., Calvert J.W., and Zhang J.H. Role of c-Jun N-Terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 36 (2005) 1538-1543
49. Yoshimoto Y., Tanaka Y., and Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 32 (2001) 1989-1993
50. Zaheer A., Sahu S.K., Wu Y., Zaheer A., Haas J., Lee K., and Yang B. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis. Brain Res. 1144 (2007) 239-247
51. Zhan Y., Brown C., Maynard E., Anshelevich A., Ni W., Ho I.C., and Oettgen P. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J. Clin. Invest. 115 (2005) 2508-2516
52. Zhou C., Yamaguchi M., Kusaka G., Schonholz C., Nanda A., and Zhang J.H. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 24 (2004) 419-431